1
|
Fytas C, Zoidis G, Tsotinis A, Fytas G, Khan MA, Akhtar S, Rahman KM, Thurston DE. Novel 1-(2-aryl-2-adamantyl)piperazine derivatives with antiproliferative activity. Eur J Med Chem 2015; 93:281-90. [PMID: 25703296 DOI: 10.1016/j.ejmech.2015.02.021] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2014] [Revised: 01/27/2015] [Accepted: 02/13/2015] [Indexed: 11/29/2022]
Abstract
Novel 1-(2-aryl-2-adamantyl)piperazine derivatives have been synthesized and evaluated in vitro for their antitumor properties against HeLa cervical carcinoma, MDA MB 231 breast cancer, MIA PaCa2 pancreatic cancer, and NCI H1975 non-small cell lung cancer. The parent piperazine 6 was found to exhibit a reasonable activity toward the HeLa and MDA MB 231 tumor cell lines (IC50= 9.2 and 8.4 μΜ, respectively). Concurrent benzene ring C4-fluorination and piperidine acetylation of the piperazino NH of compound 6 resulted in the most active compound 13 of the series in both of the above cell lines (IC50=8.4 and 6.8 μΜ, respectively). Noticeably, compounds 6 and 13 exhibited a significantly low cytotoxicity level over the normal human cells HUVEC (Human Umbilical Vein Endothelial Cells) and NHDF (Normal Human Dermal Fibroblasts).
Collapse
Affiliation(s)
- Christos Fytas
- School of Health Sciences, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, University of Athens, Panepistimioupoli-Zografou, GR-15784 Athens, Greece
| | - Grigoris Zoidis
- School of Health Sciences, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, University of Athens, Panepistimioupoli-Zografou, GR-15784 Athens, Greece
| | - Andrew Tsotinis
- School of Health Sciences, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, University of Athens, Panepistimioupoli-Zografou, GR-15784 Athens, Greece
| | - George Fytas
- School of Health Sciences, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, University of Athens, Panepistimioupoli-Zografou, GR-15784 Athens, Greece.
| | - Mohsin A Khan
- Institute of Pharmaceutical Sciences, King's College London, Britannia House, 7 Trinity Street, London SE1 1DB, UK
| | - Samar Akhtar
- Institute of Pharmaceutical Sciences, King's College London, Britannia House, 7 Trinity Street, London SE1 1DB, UK
| | - Khondaker M Rahman
- Institute of Pharmaceutical Sciences, King's College London, Britannia House, 7 Trinity Street, London SE1 1DB, UK
| | - David E Thurston
- Institute of Pharmaceutical Sciences, King's College London, Britannia House, 7 Trinity Street, London SE1 1DB, UK
| |
Collapse
|
2
|
Papanastasiou I, Tsotinis A, Kolocouris N, Nikas SP, Vamvakides A. New aminoadamantane derivatives with antiproliferative activity. Med Chem Res 2013. [DOI: 10.1007/s00044-013-0798-7] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
|
3
|
Fytas C, Zoidis G, Fytas G. A facile and effective synthesis of lipophilic 2,6-diketopiperazine analogues. Tetrahedron 2008. [DOI: 10.1016/j.tet.2008.05.005] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
4
|
Radić B, Vrdoljak AL, Petek MJ, Kopjar N, Zeljezić D. In vitro biological efficiency of tenocyclidine – TCP and its adamantane derivative TAMORF. Toxicol In Vitro 2006; 20:1455-64. [PMID: 16942853 DOI: 10.1016/j.tiv.2006.07.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2006] [Revised: 06/01/2006] [Accepted: 07/05/2006] [Indexed: 11/19/2022]
Abstract
Tenocyclidine-TCP showing a broad spectrum of pharmacological activity including antidotal effect in organophosphorus compounds poisoning, radioprotective and anticancer effects. We investigated in vitro interactions of TCP and its adamantane derivative--TAMORF with human erythrocyte acetylcholinesterase (AChE). Moreover, their genotoxicity and radioprotective activity on human white blood cells were studied using the alkaline comet assay, viability testing and the analysis of the structural chromosome aberrations. The tested compounds were found to be weak inhibitors of AChE, for TCP IC(50)=1 x 10(-5)M and for TAMORF IC(50)>1 x 10(-3)M, without reactivating and protective effects on AChE inhibited by soman. Results suggest that TCP modified by the replacement of the cyclohexyl ring with an adamantly ring and piperidine with morpholine group (TAMORF) have lower toxicity. Both compounds possess low cytotoxicity and radioprotective activity, but TAMORF also shows cell growth inhibitory effects. To clarify differences in their biological efficiency observed in vitro and in vivo, additional analyses are necessary. Since TAMORF was found to significantly inhibit cell growth and proliferation in vitro, it is reasonably to consider it as a source molecule promising for further modifications and development of more potent substances with antitumor properties rather then radioprotector or antidote in organophosphorus poisoning.
Collapse
Affiliation(s)
- Bozica Radić
- Institute for Medical Research and Occupational Health, Ksaverska c. 2, HR-10 000 Zagreb, Croatia
| | | | | | | | | |
Collapse
|
5
|
Causey PW, Dubovyk I, Leznoff CC. Syntheses and characterization of phthalonitriles and phthalocyanines substituted with adamantane moieties. CAN J CHEM 2006. [DOI: 10.1139/v06-096] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
The reaction of 3,4,5,6-tetrafluorophthalonitrile with 1-adamantanol, 1-adamantylamine, 1-adamantanemethanol, and 1-adamantaneethanol gave 4,5-di-(1-adamantyloxy)-3,6-difluorophthalonitrile, 4,5-di-(1-adamantylamino)-3,6-difluorophthalonitrile, 4-(1-adamantylamino)-3,5,6-trifluorophthalonitrile, 3,4,5,6-tetra-(1-adamantylmethoxy)phthalonitrile, and 3,4,5,6-tetra-(1-adamantylethoxy)phthalonitrile, respectively. The conversion of these tetrasubstituted phthalonitriles to magnesium, nickel, and metal-free phthalocyanines was demonstrated. These highly hindered phthalocyanines exhibited interesting red shifts in their UV–vis spectra.Key words: highly hindered adamantane phthalocyanines, adamantylphthalonitriles.
Collapse
|